High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.

Background: The antitumor agent taurolidine (TRD) affects tumor growth in animals. Thus far, no animal studies have been published concerning the systemic or local toxicity and the effectiveness of long-term intraperitoneal (i.p.